Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-382277

Chief Operating Officer sold 10,000 shares at $208.65 ($2,086,500)

  • Chief Operating Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jacobson Mark L. Chief Operating Officer 2026-09-03 Option exercise 10b5-1 +10,000 $12.95 $129,500 10,000 D: show line 1 in the form
Jacobson Mark L. Chief Operating Officer 2026-09-03 Sale 10b5-1 −10,000 $208.65 $2,086,500 0 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $208.65 · $2,086,500

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jacobson Mark L. Chief Operating Officer 2026-09-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 104,954 D: show line 3 in the form
Loading xslF345X06/ownership.xml…